Thomson Pharma Partnering is powered by IDdb, recognized as the world leader in drug pipeline information, and supported by the renowned expertise and objectivity of Thomson Reuters.

Essential knowledge for those seeking to in-license drugs or acquire companies

• Determine which assets to pursue.
• Find the companies best able to develop and market your drugs.
• Evaluate each opportunity quickly and efficiently, so that you can concentrate only on those that have serious potential.
• Review summaries of deals comparable to your own, giving you a unique insight into the terms you can expect, and whether or not you’re in the position to make the arrangement you want.
  
  

Essential knowledge for those seeking to partner their assets

• Every piece of information has been assessed and analyzed by a pool of senior scientists, built up over many years, and is managed by respected industry experts who ensure it remains fully up to date.
• The comprehensive company profiles—covering the world’s major pharmaceutical innovators, emerging companies and non-profit research centers—include graphs summarizing the state of their drug pipelines, giving you a quick and easy overview of their activities and the health of their business.
• The profiles also contain a thorough report of each drug, along with its history, pre-clinical and clinical development, and licensing agreements.